UNSPSC 51431708: Diltiazem hydrochloride

This classification denotes a calcium channel blocker with the molecular formula C22H26N2O4S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OLH94387TE, chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride, (+)-cis- but more generally known as diltiazem hydrochloride, which bears US NIH Compound Identifier 62920.

UNSPSC 51431708 Diltiazem hydrochloride, a Commodity code, represents emergency and critical-care medications purchased by state and local public safety and healthcare agencies. State and local governments procure this cardiac medication—specifically diltiazem vials and injections—as part of advanced life support drug supplies for fire rescue services, emergency medical services (EMS), and hospital systems. Recent solicitations show these purchases bundled with other cardiovascular and emergency medications (epinephrine, adenosine, labetalol) in fixed-term supply contracts. Issuing bodies are primarily municipal fire and rescue departments and city purchasing offices acting on behalf of emergency services; hospital systems and county health departments also source these medications under similar codes. Diltiazem procurement typically follows rigid specification and compliance requirements, including minimum shelf-life warranties (often nine months or more from delivery), OSHA-compliant Safety Data Sheets, and warranty provisions covering defect-free materials for extended periods.

The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00 and a bid deadline of April 8, 2026. The solicitation specified 1,020 units of diltiazem 25mg vials alongside three other emergency medications, required delivery within ten calendar days of order, and included a 5 percent Small Local Business Enterprise (SLBE) bid discount not to exceed $10,000. The contract term runs one year from award with two optional one-year renewals and up to three unilateral 30-day extensions. The source shows limited recent activity; only one representative opportunity in the recent block ties directly to the code, reflecting the specialized and typically lower-volume nature of individual pharmaceutical SKU procurement at the state and local level.